iShares Health Innovation Active ETF (BMED)

Assets	$10.05M
Expense Ratio	0.55%
PE Ratio	22.80
Shares Out	360,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	9,359
Open	28.05
Previous Close	27.88
Day's Range	28.00 - 28.11
52-Week Low	23.59
52-Week High	32.19
Beta	0.75
Holdings	60
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

44.46% of assets

Name	Symbol	Weight
Johnson & Johnson	JNJ	8.07%
Gilead Sciences, Inc.	GILD	5.51%
BlackRock Cash Funds Treasury SL Agency	XTSLA	4.87%
Edwards Lifesciences Corporation	EW	4.77%
Merck & Co., Inc.	MRK	4.20%
Biogen Inc.	BIIB	3.74%
Amgen Inc.	AMGN	3.51%
Waters Corporation	WAT	3.50%
WuXi Biologics (Cayman) Inc.	2269	3.25%
Vertex Pharmaceuticals Incorporated	VRTX	3.04%

Performance

BMED had a total return of 17.99% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.68%.